Bausch Health Companies Inc.BHCNYSE
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank64
3Y CAGR+11.2%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+11.2%/yr
vs -11.7%/yr prior
Acceleration
+22.8pp
Accelerating
Percentile
P64
Within normal range
vs 3Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 16.56% |
| 2024 | 4.97% |
| 2023 | 13.96% |
| 2022 | 12.05% |
| 2021 | -2.47% |
| 2020 | -6.01% |
| 2019 | 16.74% |
| 2018 | 19.78% |
| 2017 | -21.32% |
| 2016 | 6.59% |